Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Partnering to build biosynthesis processes and a pharmaceutical production platform
Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects
The company is focused on the development of novel treatments for RNA viruses
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
In addition to supporting the ongoing development of the first IND-approved product in clinical trials, the proceeds will also be used to expand the 3D printed drug product pipeline
Subscribe To Our Newsletter & Stay Updated
